The NYONRC has created numerous strong research collaborations leading to scientific advances in obesity (Exhibit IV). The focus of the Research Base (RB) is described by themes below. The use of Core Laboratories for training, consultation, and service is high. In 2005, we added the Albert Einstein College of Medicine (AECOM). The scientists added to the RB are productive investigators who have added strength to the RB. There are 76 Members. Total RB funding is $71,715,484, with 31% from NIDDK and 81% from NIH. The instructions for this grant application state that only persons at our institutions can be listed in the RB. We have a large number of collaborations with outside scientists. This actually seems the intent of the NIH Roadmap: widening collaborations for greater productivity. These relationships are multiple and growing. The NYONRC has been funded for 29 yrs. In the past decade there have been striking changes in the prevalence of obesity and its co-morbidities, with institution of more aggressive interventions, including surgery and more rationally designed pharmaceuticals and radical changes in research strategies. The latter derive from the combination of molecular cloning of rodent obesity genes, sequencing of the mouse and human genomes, introduction of transgenic manipulations, availability of massive parallel gene expression arrays, accession of powerful bioinformatics techniques for dense genetic analysis, newer brain imaging, and the advent of sophisticated methods for characterizing humans and mice for energy homeostasis phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
7P30DK026687-35
Application #
8893954
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (J2))
Program Officer
Evans, Mary
Project Start
1996-12-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
35
Fiscal Year
2015
Total Cost
$1,225,948
Indirect Cost
$398,941
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Carli, Jayne F Martin; LeDuc, Charles A; Zhang, Yiying et al. (2018) The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function. FASEB J 32:3946-3956
Gallagher, Dympna; Rosenn, Barak; Toro-Ramos, Tatiana et al. (2018) Greater Neonatal Fat-Free Mass and Similar Fat Mass Following a Randomized Trial to Control Excess Gestational Weight Gain. Obesity (Silver Spring) 26:578-587
Rosenbaum, Michael; Goldsmith, Rochelle L; Haddad, Fadia et al. (2018) Triiodothyronine and leptin repletion in humans similarly reverse weight-loss induced changes in skeletal muscle. Am J Physiol Endocrinol Metab :
Gallagher, Dympna; Rizkalla, Bridgette (2018) The 11th International Symposium on In Vivo Body Composition Studies. Eur J Clin Nutr :
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Blumenfeld, Nicole R; Kang, Hwan June; Fenzl, Anna et al. (2018) A direct tissue-grafting approach to increasing endogenous brown fat. Sci Rep 8:7957
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Shechter, Ari; Kim, Elijah Wookhyun; St-Onge, Marie-Pierre et al. (2018) Blocking nocturnal blue light for insomnia: A randomized controlled trial. J Psychiatr Res 96:196-202
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35

Showing the most recent 10 out of 809 publications